Scleroderma

Top Story

Direct-to-consumer genetic testing not ready for prime time in rheumatology

Direct-to-consumer genetic testing not ready for prime time in rheumatology
January 18, 2019

Blood test for scleroderma, systemic sclerosis biomarkers launched

January 10, 2019
Specialty biotechnology company Gemelli Biotech has announced the launch of a blood test that measures anti-vinculin levels to help physicians identify the risk of…
In the Journals

Cardiovascular comorbidity burden similar in RA, systemic sclerosis

December 26, 2018
The burden of cardiovascular comorbidities is similar between rheumatoid arthritis and systemic sclerosis, despite dyslipidemia and diabetes mellitus being nearly half…
In the Journals

Decline in lung function better predictor of mortality risk in SSc-ILD

December 6, 2018
Among patients with interstitial lung disease related to systemic sclerosis, diminished forced vital capacity and a decline in the diffusing capacity for carbon monoxide…
More Headlines »
CME

Highlights of the Rheumatology Summit: A Master Class in RA, PsA, and SpA

This activity is supported by independent educational grants from AbbVie; Celgene Corporation; Lilly USA, LLC; Merck & Co., Inc.; and Pfizer, Inc.

This CME-certified monograph is specifically designed for health care professionals to advance their knowledge…
More »
Video
Meeting News

VIDEO: A1 polymorphism linked to atherosclerosis

December 15, 2016
More »
CME

Multidisciplinary Perspectives in Giant Cell Arteritis: A Team-based Approach for Improved Quality of Care

This activity is supported by an educational grant from Genentech, Inc.

Giant cell arteritis (GCA) is the most common form of medium- and large-vessel vasculitis. If left untreated, patients…
More »